2.61
2.61 (0%)
As of Feb 14, 2025
Tela Bio, Inc. [TELA]
Source:
Company Overview
Tela Bio, Inc. is a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy.
| Country | United States |
| Headquarters | malvern, pennsylvania |
| Phone Number | ( 484 ) 320-2930 |
| Industry | manufacturing |
| CEO | Antony Koblish |
| Website | www.telabio.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $69.3 |
| Operating Profit | $-34.1 |
| Net Income | $-37.8 |
| Net Cash | $5.9 |
Profit Ratios
| Gross Margin | $46.5 |
| Operating Margin | -49.2 |
| Profit as % of Revenues | -122.9% |
| Profit as % of Assets | -46% |
| Profit as % of Stockholder Equity | -133% |
Management Effectiveness
| Return on Equity | -133% |
| Return on Assets | -43.7% |
| Turnover Ratio | 84.2% |
| EBITA | $-34.1 |
Balance Sheet and Cash Flow Measures
| Total Assets | $86.6 |
| Total Liabilities | $58.1 |
| Operating Cash Flow | $-41.6 |
| Investing Cash Flow | $4.5 |
| Financing Cash Flow | $43.1 |
